IMRN

IMMURON LTD

IMRN·45254U101·US·ADR·Healthcare - Biotechnology

IMRN (IMMURON LTD) is held by 6 institutional investors as of Q2 2026. Largest holders: CITADEL ADVISORS LLC ($45,710), RHUMBLINE ADVISERS ($7,808), BNP PARIBAS FINANCIAL MARKETS ($5,512). Net institutional sentiment: Mixed.

6
Holders
$61,238
Total Value
57% (7)
Consensus
4 buying - 3 selling
13F: Insider & Congress: Updated regularly
IMRN

Smart Money Verdict

View all
Loading verdict
Held by 6 funds

Who's Trading

Source dates: Price Aug 28, 2026 · Insiders none · Activists none · Congress none

No recent insider, activist, or congressional trades for IMRN.

Top Holders

Checking access…
Fund
Action
Shares
Value
Weight
Est. P&L
Conviction
Increased
43,123(+212.4%)$45,7100.0%+1.71%
22
Unchanged
7,367$7,8080.0%-37.38%
0
Increased
5,200(+13.0%)$5,5120.0%+6.20%
12
Decreased
1,700(-94.4%)$1,8020.0%+1.67%
0
New
363$3850.0%+7.55%
17
New
20,584$210.0%+7.55%
17
Exited
0(-100.0%)$1740.0%+43.24%
0
Exited
0(-100.0%)$13,4680.0%-37.58%
0
IMRNIMRNIMMURON LTD

Other Healthcare stocks held by institutions

Data sourced from four public-disclosure sources: SEC 13F, Form 4, 13D/13G, and House/Senate STOCK Act disclosures. Not financial advice. Full disclaimer

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used